Today

Agents

Chat

Arena

Discover

More

App

Seres Therapeutics Q2 EPS USD 0.47 - MCRB News | Rallies

Seres Therapeutics Q2 EPS USD 0.47

MCRB•2026-08-05

Second-quarter results

Aug. 5 (Reuters) - Seres Therapeutics Q2 operating income was USD -21.273 million.

Q2 operating expenses: USD 22.009 million
Q2 collaboration revenue: USD 736 thousand
Q2 net income: USD 4.581 million

Related News

Super Group to participate in upcoming investor conferences and non-deal roadshows

SGHC•2026-08-05

Cheche Group regains Nasdaq compliance with US$ 1 minimum bid-price rule

CCG•2026-08-05

SolarEdge Announces Second Quarter 2026 Financial Results

•

2026-08-05

Cmc Announces $600 Million Increase In Share Repurchase Program Authorization

CMC•2026-08-05

J.M. Smucker publishes financial calendar update

SJM•2026-08-05